Investor Relations
-
Message from Leadership
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
Message from Leadership
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
-
Stock Price
Last-
Change-
Chart
-
News Press Release
- Sysmex Launches “HISCL™ HIT IgG Assay Kit” Contributing to the Detection of Adverse Reactions to Heparin Therapy
-
News Press Release
- Announcement of Executive Change (PDF：119KB)
-
News Press Release
- Sysmex Applies for Manufacturing and Marketing Approval of an Assay Kit to Predict the Risk of Adverse Reactions from Anti-amyloid β Antibody Drugs for Alzheimer’s Disease
- Determining the APOE Genotype from Genomic DNA in Blood - -
News Press Release
- Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025 (PDF：299KB)
-
News Press Release
- Sysmex Expands Strategic Alliance Agreement with QIAGEN in the Field of Genetic Testing
Download the Latest IR Materials
Click Here
for File Details
Data Included in the Zip File
Consolidated Financial Results for the Fiscal Year Ending March 31, 2025- Financial Statements
- Presentation
- Financial Data
